NEJM上关于疫苗对抗Delta变异效果的文章

n
nj_guy
楼主 (北美华人网)
New England Journal of Medicine上的文章:Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant。
主要结果: Effectiveness after one dose of vaccine (BNT162b2 or ChAdOx1 nCoV-19) was notably lower among persons with the delta variant (30.7%; 95% confidence interval [CI], 25.2 to 35.7) than among those with the alpha variant (48.7%; 95% CI, 45.5 to 51.7); the results were similar for both vaccines. With the BNT162b2 vaccine, the effectiveness of two doses was 93.7% (95% CI, 91.6 to 95.3) among persons with the alpha variant and 88.0% (95% CI, 85.3 to 90.1) among those with the delta variant. With the ChAdOx1 nCoV-19 vaccine, the effectiveness of two doses was 74.5% (95% CI, 68.4 to 79.4) among persons with the alpha variant and 67.0% (95% CI, 61.3 to 71.8) among those with the delta variant.

https://www.nejm.org/doi/full/10.1056/NEJMoa2108891
a
awesomeiris
赞。效果还是不错
A
AlaskaNYC
93.7% ---88.0% 还可以啊
n
nj_guy
应该是今天发表的。对于delta变异,Pfizer的有效性是88%,AstraZenica是67%
v
vitd120
这不还是5月那篇文章嘛,刚发出来

R
Ruth
我记得之前新闻看到过好些不同数字,以色列的64,英国的88,美国的92,还记得有一个96。
n
nj_guy
这不还是5月那篇文章嘛,刚发出来


vitd120 发表于 2021-07-21 21:36

内容是以前就漏出来过了,但今天是正式发表,数据的可信度不一样。
v
vitd120
内容是以前就漏出来过了,但今天是正式发表,数据的可信度不一样。
nj_guy 发表于 2021-07-21 21:38

哦-_-
l
liumajia
今天看了个新闻说印度有抗体的人达到了差不多70%,他们是不是也安全了,还是说病毒还有继续变异的可能性?